All Neurology articles
-
Formulary decision guideIpinnia® XL (ropinirole hydrochloride) prolonged-release tablets
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13 Date of preparation: September 2021 -
Top tips
Top tips: ADHD in children and young people
Dr Natasha Halliwell offers 10 top tips on the identification and management of attention deficit hyperactivity disorder in children and young people
-
Key learning points
Key learning points: NICE cannabis-based medicinal products
Dr David Spraggett outlines five key learning points to take away from the 2019 NICE guideline on cannabis-based medicinal products
-
Key learning points
Key learning points: BAP insomnia and sleep disorders
Professor Niroshan Siriwardena highlights the relevant recommendations for primary care from the British Association of Psychopharmacology guideline on insomnia and sleep disorders
-
Key learning points
Key learning points: NICE stroke and TIA
Dr Ivan Benett identifies five key learnings for primary care from the new NICE guideline on stroke and transient ischaemic attack (TIA)
-
News
Guideline on cerebral palsy in adults published by NICE
NICE has published NICE Guideline (NG) 119 on Cerebral palsy in adults.
-
News
RCP updates guideline on pain syndrome in adults
The Royal College of Physicians (RCP) has published the second edition of Complex regional pain syndrome in adults—UK guidelines for diagnosis, referral and management in primary and secondary care.
-
Implementing guidelines
Lyme disease: when to suspect and how to manage
Dr Caroline Rayment discusses how the new NICE guideline will help practitioners provide early and consistent treatment to patients with suspected Lyme disease
-
Implementing guidelines
Updated guideline on ADHD defines the role of primary care
Dr Natasha Halliwell examines the latest recommendations from NICE on recognising, treating, and managing attention deficit hyperactivity disorder
-
Test and reflect
SIGN 155 guideline on the pharmacological management of migraine
This Guidelines in Practice CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on managing migraine in primary care—you will then be prompted to reflect on your learning.
-
News
NICE revises ADHD guideline
NICE has published NG87 on Attention deficit hyperactivity disorder: diagnosis and management.
-
News
SIGN updates advice on managing migraine
The Scottish Intercollegiate Guidelines Network has published SIGN 155 on Pharmacological management of migraine, including a treatment pathway algorithm.
-
Top tips
Top tips: ADHD in adults
Dr Rob Baskind provides top tips for the primary care management of adults with attention deficit hyperactivity disorder and advice on the referral process
-
News
Quality standard on cerebral palsy in children and young people published by NICE
NICE has published Quality Standard (QS) 162 on cerebral palsy in children and young people
-
Top tips
Top tips: Parkinson’s disease
Dr Shahid Dadabhoy discusses some key points in the diagnosis and management of Parkinson’s disease in primary care
-
News
NICE updates Parkinson’s disease in adults guideline
NICE has published an update to NICE Guideline (NG) 71 on Parkinson’s disease in adults.
-
Implementing guidelines
Structured face-to-face annual review is key for adults with epilepsy
Dr Anne Coker reviews SIGN Guideline 143 on adults with epilepsy and the recommendations for specific patient groups including people with psychiatric conditions
-
NICE quality standard article
New quality standards on the epilepsies will promote better care
Professor Helen Cross and Drs Colin Dunkley and Margaret Jackson explain how an integrated approach to epilepsy care could avoid misdiagnosis and improve outcomes for patients
-
Implementing guidelines
NICE updates its recommendations on treatment of epilepsy
Dr Greg Rogers outlines how the NICE guideline on epilepsy will help clinicians to choose the most appropriate drug based on seizure type and syndrome
-
Implementing guidelines
Prompt referral is required for suspected new epileptic seizures
Dr Simon de Groot explains how management of patients with epilepsy remains poor despite availability of guidance and recognition of the impact of the condition
